Translating induced pluripotent stem cells from bench to bedside: Application to retinal diseases

Current Gene Therapy

Volumn 13, Issue 2, 2013, Pages 139-151

  Cramer, Alona O ^a,b   MacLaren, Robert E ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MERTON COLLEGE   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Clinical trial; Disease modeling; Induced pluripotent stem cell; Photoreceptor; Reprogramming; Retinal degeneration; Stem cell; Transplantation

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; HLA ANTIGEN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OPSIN; RHODOPSIN; SOMATOMEDIN C RECEPTOR; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2;

CANCER CELL; CARCINOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; EMBRYONIC STEM CELL; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; IMPLANTATION; INTRACELLULAR SIGNALING; NERVE REGENERATION; NONHUMAN; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPIC VARIATION; PHOTORECEPTOR CELL; PHOTOSENSITIVITY; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; RETINA DEGENERATION; RETINA DISEASE; RETINA GANGLION CELL; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; SENDAI VIRUS; SICKLE CELL ANEMIA; SKIN FIBROBLAST; STEM CELL TRANSPLANTATION; VISUAL IMPAIRMENT; VISUAL PROSTHESIS; WNT SIGNALING PATHWAY;

CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; RETINA; RETINAL DEGENERATION; RETINAL DISEASES; TRANSLATIONAL MEDICAL RESEARCH;

ANIMALIA; IPS;

EID: 84876720929     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/1566523211313020008     Document Type: Review

References (120)

1. Gurdon JB. Adult frogs derived from the nuclei of single somatic cells. Dev Biol 1962; 4:256-273.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
3. MacLaren RE. Re-establishment of visual circuitry after optic nerve regeneration. Eye (Lond) 1999; 13:277-284.
4. Sung CH, Chuang JZ. The cell biology of vision. J Cell Biol 2010; 190:953-963.
5. MacLaren RE, Taylor JS. Regeneration in the developing optic nerve: correlating observations in the opossum to other mammalian systems. Prog Neurobiol 1997; 53(3):381-398.
6. Stone JL, Barlow WE, Humayun MS, de Juan E Jr, Milam AH. Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol 1992; 110:1634.
7. Vidal-Sanz M, Bray GM, Villegas-Pérez MP, et al. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci 1987; 7:2894-2909.
8. Whiteley SJ, Sauvé Y, Avilés-Trigueros M, et al. Extent and duration of recovered pupillary light reflex following retinal ganglion cell axon regeneration through peripheral nerve grafts directed to the pretectum in adult rats. Exp Neurol 1998; 154:560-572.
9. Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 2011; 278(1711):1489-1497.
10. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006; 444(7116), 203-207.
11. Singh MS, Charbel Issa P, Butler R, et al. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation; PNAS 2013; Published online before print, January 3. http://www.pnas.org/content/110/3/1101.full.
12. Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx- deficient mice. Cell Stem Cell 2009; 4:73-79.
13. Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embry- onic stem cells in preclinical models of macular degeneration. Stem Cells 2009; 27:2126-2135.
14. Aboody K, Capela A, Niazi N, Stern JH, Temple S. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta Stone. Neuron 2011; 70(4): 597-613.
15. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012; 379(9817): 713-720.
16. Singh MS, MacLaren RE. Stem cells as a therapeutic tool for the blind: biology and future prospects. Proc Biol Sci 2011; 278(1721): 3009-3016.
17. Michalakis S, Muhlfriedel R, Tanimoto N, et al. Restoration of Cone Vision in the CNGA3(2/2) Mouse Model of Congenital Complete Lack of Cone Photoreceptor Function. Hum Gene Ther 2010; 21: 1181.
18. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
19. Jin ZB, Okamoto S, Osakada F, et al. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PloS one 2011; 6(2): e17084.
20. Jin ZB, Okamoto S, Mandai M, Takahashi, M. Induced pluripotent stem cells for retinal degenerative diseases: a new perspective on the challenges. J Genet 2009; 88(4): 417-424.
21. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477-485.
22. Sahel JA, Mohand-Said S, Léveillard T, et al. Rod-cone interdependence: implications for therapy of photoreceptor cell diseases. Prog Brain Res 2001; 131: 649-661.
23. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in agerelated macular degeneration. Invest. Ophthalmol Vis Sci 1996; 37: 1236-1249.
24. Nguyen M, Arnheiter H. Signaling and transcriptional regulation in early mammalian eye development: a link between FGF and MITF. Development 2000; 127: 3581-3591.
25. Furukawa T, Kozak CA, Cepko CL. Rax, a novel paired-type homeobox gene, shows expression in the anterior neural fold and developing retina. Proc Natl Acad Sci U.S.A 1997; 94: 3088-3093.
26. Furukawa T, Morrow EM, Cepko CL. Crx, a novel otx-like homeobox gene, shows photoreceptor-specific expression and regulates photoreceptor differentiation. Cell 1997; 91: 531-541.
27. Meyer JS, Shearer RL, Capowski EE, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 2009; 106: 16698-16703.
28. Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, et al. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 2001; 1: 423-434.
29. Bachiller D, Klingensmith J, Kemp C, et al. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 2000; 403: 658-661.
30. Lamb TM, Knecht AK, Smith WC, et al. Neural induction by the secreted polypeptide noggin. Science 1993; 262: 713-718.
31. Smith WC, Knecht AK, Wu M, Harland RM. Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature 1993; 361: 547-549.
32. Hemmati-Brivanlou A, Kelly OG, Melton DA. Inhibition of activin receptor signaling promotes neuralization in Xenopus laevis. Cell 1994; 77: 283-295.
33. Pera EM, Wessely O, Li SY, De Robertis EM. Neural and head induction by insulin-like growth factor signals. Dev Cell 2001; 1: 655-665.
34. Jadhav AP, Mason HA, Cepko CL. Notch 1 inhibits photoreceptor production in the developing mammalian retina. Development 2006; 133: 913-923.
35. Ikeda H, Osakada F, Watanabe K, et al. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci U S A 2005; 102: 11331-11336.
36. Osakada F, Ikeda H, Mandai M, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 2008; 26: 215-224.
37. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc 2009; 4: 811-824.
38. Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA 2006; 103: 12769-12774.
39. Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126-131.
40. Osakada F, Sasai Y, Takahashi M. Control of neural differentiation from pluripotent stem cells. Inflamm Regen 2008; 28: 166-173.
41. Melyan Z, Tarttelin EE, Bellingham J, et al. Addition of human melanopsin renders mammalian cells photoresponsive. Nature 2005; 433: 741-745.
42. Jin ZB, Okamoto S, Xiang P, Takahashi M. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Transl Med 2012; 1(6): 503-509.
43. Buchholz DE, Hikita ST, Rowland TJ, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009; 27(10): 2427-2434.
44. Tucker BA, Park IH, Qi SD, et al. Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice. PLoS ONE 2011; 6(4).
45. Zhou L, Wang W, Liu Y, et al. Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem cells 2011; 29(6): 972-980.
46. Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PloS one 2010; 5(1).
47. Carr A-J, Vugler AA, Hikita ST, et al. Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat. PLoS ON, 2009; 4(12).
48. Westenskow PD, Moreno SK, Krohne TU, et al. Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells. Invest Ophthalmol Vis Sci 2012; 53(10):6282-6290.
49. Pearson RA, Barber AC, West EL, et al. Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant 2010; 19: 487-503.
50. Yao J, Tao SL, Young MJ. Synthetic Polymer Scaffolds for Stem Cell Transplantation in Retinal Tissue Engineering. Polymers 2011; 3(2): 899-914.
51. Jeffery G. The albino retina: an abnormality that provides insight into normal retinal development. Trends Neurosci 1997; 20: 165-169.
52. Gosens I, den Hollander AI, Cremers FP, Roepman R. Composition and function of the Crumbs protein complex in the mammalian retina. Exp Eye Res 2008; 86:713-726.
53. Comyn O, Lee E, MacLaren RE. Induced pluripotent stem cell therapies forretinal disease. Curr Opin Neurol 2010; 23(1): 4-9.
54. Bartsch U, Oriyakhel W, Kenna PF, et al. Retinal cells integrate into the outer nuclear layer and differentiate into mature photoreceptors after subretinal transplantation into adult mice. Exp Eye Res 2008; 86: 691-700.
55. Eberle D, Kurth T, Santos-Ferreira T, Wilson J, Corbeil D, Ader M. Outer segment formation of transplanted photoreceptor precursor cells. PloS one 2012; 7(9).
56. Redenti S, Neeley WL, Rompani S, et al. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials 2009; 30(20): 3405-3414.
57. Nakano T, Ando S, Takata N, et al. Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCs. Cell Stem Cell 2012; 10(6): 771-785.
58. Eiraku M, Takata N, Ishibashi H, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011; 472: 51-56.
59. Seiler MJ, Aramant RB. Intact sheets of fetal retina transplanted to restore damaged rat retinas. Invest. Ophthalmol Vis Sci 1998; 39: 2121-2131.
60. Ghosh F, Johansson K, Ehinger B. Long-term full-thickness embryonic rabbit retinal transplants. Invest Ophthalmol Vis Sci 1999; 40: 133-142.
61. Zhang Y, Arner K, Ehinger B, Perez MT. Limitation of anatomical integration between subretinal transplants and the host retina. Invest Ophthalmol Vis Sci 2003; 44: 324-331.
62. Seiler MJ, Thomas BB, Chen Z, Wu R, Sadda SR, Aramant RB. Retinal transplants restore visual responses: trans-synaptic tracing from visually responsive sites labels transplant neurons. Eur J Neurosci 2008; 28: 208-220.
63. Kaplan HJ, Fernandez de Castro JP. Retinal regeneration and stem cell therapy in retinitis pigmentosa. Taiwan J Ophthalmol 2012; 2(2): 41-44.
64. Li ZY, Possin DE, Milam AH. Histopathology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology 1995; 102: 805-816.
65. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-886.
66. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 2009; 106: 9826-9830.
67. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321:1218-1221.
68. Itzhaki I, Maizels L, Huber I, et al. Modeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells. J Am Coll Cardiol 2012; 60(11): 990-1000.
69. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134:877-886.
70. Tucker BA, Scheetz TE, Mullins RF, et al. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germcell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A 2011; 108: E569-E576.
71. Schwartz SB, Aleman TS, Cideciyan AV, Swaroop A, Ja-cobson SG, Stone EM. De novo mutation in the RP1 gene (Arg677ter) associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2003; 44: 3593-3597.
72. Jin ZB, Gu F, Matsuda H, Yukawa N, Ma X, Nao-i N. Somatic and gonadalmosaicism in X-linked retinitis pigmentosa. Am J Med Genet 2007; 143: 2544-2548.
73. Hanna J, Wernig M, Markoulaki S, et al. Treatment of mouse model with iPS cells generated from autologous skin. Science 2007; 318: 1920-1923.
74. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
75. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-106.
76. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26: 1269-1275.
77. Mah N, Wang Y, Liao MC, et al. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network. PLoS One 2011; 6:e24351.
78. Drews K, Jozefczuk J, Prigione A, Adjaye J. Human induced pluripotent stem cells-from mechanisms to clinical applications. J Mol Med 2012; 90 (7): 735-745.
79. Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132-1135.
80. Kawamura T, Suzuki J, Wang YV, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460: 1140-1144.
81. Li H, Collado M, Villasante A, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009; 460: 1136-1139.
82. Marion RM, Strati K, Li H, et al. A p53- mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460: 1149-1153.
83. Utikal J, Polo JM, Stadtfeld M, et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009; 460: 1145-1148.
84. Zhao Y, Yin X, Qin H, et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008; 3: 475-479.
85. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-7495.
86. Pasi CE, Dereli-Öz A, Negrini S, et al. Genomic instability in induced stem cells. Cell Death Differ 2011; 18(5): 745-753.
87. Carey BW, Markoulaki S, Hanna J, et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 2009; 106: 157-162.
88. Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. Generation of human- induced pluripotent stem cells. Nat Protoc 2008; 3: 1180-1186.
89. Welstead GG, Brambrink T, Jaenisch R. Generating iPS cells from MEFS through forced expression of Sox-2, Oct-4, c-Myc, and Klf4. J Vis Exp 2008; 14: 734.
90. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953.
91. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-106.
92. Sommer CA, Stadtfeld M, Murphy GJ, et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009; 27: 543-549.
93. Shao L, Feng W, Sun Y, et al. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 2009; 19: 296-306.
94. Gonzalez F, Barragan Monasterio M, Tiscornia G, et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A 2009; 106: 8918-8922.
95. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953.
96. Cheng L, Hansen NF, Zhao L, et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 2012; 10(3): 337-344.
97. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953.
98. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
99. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766-770.
100. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771-775.
101. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472-476.
102. Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8(4): 376-388.
103. Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 2011; 6(1): 78-88.
104. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212-215.
105. Pasi CE, Dereli-Öz A, Negrini S, et al. Genomic instability in induced stem cells. Cell Death Differ 2011; 18(5): 745-753.
106. Mayshar Y, Ben-David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7:521-531.
107. Prigione A, Hossini AM, Lichtner B, et al. Mitochondrialassociated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One 2011; 6: e27352.
108. Wolfrum K, Wang Y, Prigione A, Sperling K, Lehrach H, Adjaye J. The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PLoS One 2010; 5:e13703.
109. Chin MH, Mason MJ, Xie W, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111-123.
110. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR. Transcriptional signature and memory retention of human induced pluripotent stem cells. PLoS One 2009; 4:e7076.
111. Ohi Y, Qin H, Hong C, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 2011; 13:541-549.
112. Hu Q, Friedrich AM, Johnson LV, Clegg DO. Memory in induced pluripotent stem cells: reprogrammed human retinal- pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 2010; 28:1981-1991.
113. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, Young RA. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 2010; 7: 249-257.
114. Ruiz S, Diep D, Gore A, et al. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. Proc Natl Acad Sci U S A 2012; 109(40): 16196-16201.
115. Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nat Biotechnol 2008; 26: 739-740.
116. Gourraud PA, Gilson L, Girard M, Peschanski M. The role of human leukocyte antigen matching in the development of multiethnic haplobank of induced pluripotent stem cell lines. Stem Cells 2012; 30(2): 180-186.
117. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2008; 366(9502): 2019-2025.
118. Rizzino A. Stimulating progress in regenerative medicine: improving the cloning and recovery of cryopreserved human pluripotent stem cells with ROCK inhibitors. Regen Med 2010; 5: 799-807.
119. Ichikawa H, Nakata N, Abo Y, et al. Gene pathway analysis of the mechanism by which the Rho-associated kinase inhibitor Y-27632 inhibits apoptosis in isolated thawed human embryonic stem cells. Cryobiology 2012; 64: 12-22.
120. Li X, Krawetz R, Liu S, Meng G, Rancourt DE. ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Hum Reprod 2009; 24: 580-589.